Satwant Narula Selected Research

RN486

9/2013	Suppression of glomerulonephritis in lupus-prone NZB × NZW mice by RN486, a selective inhibitor of Bruton's tyrosine kinase.
4/2012	RN486, a selective Bruton's tyrosine kinase inhibitor, abrogates immune hypersensitivity responses and arthritis in rodents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satwant Narula Research Topics

Disease

4	Arthritis (Polyarthritis) 08/2015 - 04/2012
4	Inflammation (Inflammations) 10/2013 - 04/2012
2	Rheumatoid Arthritis 02/2013 - 04/2012
1	Autoimmune Diseases (Autoimmune Disease) 10/2013
1	Nephritis 09/2013
1	Disease Progression 09/2013
1	Glomerulonephritis 09/2013
1	Pneumonia (Pneumonitis) 08/2013
1	Asthma (Bronchial Asthma) 08/2013
1	Hypersensitivity (Allergy) 04/2012
1	Immune Complex Diseases (Immune Complex Disease) 04/2012
1	Experimental Arthritis 04/2012
1	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2003

Drug/Important Bio-Agent (IBA)

4	Agammaglobulinaemia Tyrosine KinaseIBA 08/2015 - 04/2012
3	CytokinesIBA 08/2015 - 02/2013
2	RN486IBA 09/2013 - 04/2012
1	Matrix Metalloproteinases (MMPs)IBA 08/2015
1	6- (2- aminocyclohexylamino)- 4- (5,6- dimethylpyridin- 2- ylamino)pyridazine- 3- carboxylic acid amideIBA 10/2013
1	Syk KinaseIBA 10/2013
1	Thymic Stromal LymphopoietinIBA 08/2013
1	Methotrexate (Mexate)FDA LinkGeneric 04/2012
1	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2003
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2003
1	Interleukin-10 (Interleukin 10)IBA 06/2003
1	Isoantigens (Alloantigen)IBA 06/2003

Therapy/Procedure

2	Therapeutics 10/2013 - 02/2013
1	Oral Administration 10/2013